StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3025% above fair value
$1410.99−6.55 (-0.46%)

Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%

Eli Lilly GAAP effective tax rate by Year

GAAP effective tax rate (%) (%)

Eli Lilly GAAP effective tax rate: 19.8% in FY2025, up 3.3 pts from a year earlier.

Latest, FY2025
19.8%
Period ended Dec 31, 2025
Change on a year earlier
+3.3 pts
16.5% in FY2024
History
3 years
Since FY2023
Sources
2
Documents cited below

Where the FY2025 figure comes from

“|| Effective tax rate - Reported | 19.7 | % | 12.5 | % | 19.8 | % | 16.5 | %”

Source: Earnings Release (Form 8-K FY2025Q4 EX-99.1) (filed 2026-02-04) ↗

Reported in Form 10-Q / 10-K MD&A, Note 13 & Form 8-K Earnings Releases.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGAAP effective tax rate (%) (%)Year on yearSource
FY2025Dec 31, 202519.8%+3.3 ptsEarnings Release (Form 8-K FY2025Q4 EX-99.1) (filed 2026-02-04) ↗
FY2024Dec 31, 202416.5%-3.6 ptsEarnings Release (Form 8-K FY2024Q4 EX-99.1) (filed 2025-02-06) ↗
FY2023Dec 31, 202320.1%–Earnings Release (Form 8-K FY2024Q4 EX-99.1) (filed 2025-02-06) ↗

Breakdown

What makes up GAAP effective tax rate

Cite this data

StockData. (2026). Eli Lilly GAAP effective tax rate (%), annual FY2023–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/tax-rate-gaap

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.